See also this year's filing and all EDGAR filings for this company.
PDF Report 0000875320_2022_VERTEX_PHARMACEUTICALS_INC_MA.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000875320, VERTEX PHARMACEUTICALS INC MA
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 9,560,600,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,402,200,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 2,469,700,000 |
| 4 | LiabilitiesCurrent | 2,142,000,000 |
| 5 | LiabilitiesNoncurrent | 494,200,000 |
| 6 | remainder_Liabilities | 696,300,000 |
| 7 | CostOfGoodsAndServicesSold | 904,200,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 840,100,000 |
| 9 | ResearchAndDevelopmentExpense | 3,051,100,000 |
| 10 | remainder_Expenses | 385,200,000 |
| 11 | remainder_Revenues | 7,574,400,000 |
| 12 | remainder_NetIncome | -51,700,000 |
| 13 | remainder_ComprehensiveNetIncome | 84,400,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 13,432,500,000 |
| 1 | Liabilities | 3,332,500,000 |
| 2 | Expenses | 5,180,600,000 |
| 3 | Revenues | 7,574,400,000 |
| 4 | StockholdersEquity | 10,100,000,000 |
| 5 | NetIncome | 2,342,100,000 |
| 6 | ComprehensiveNetIncome | 2,384,300,000 |
| 7 | BaseVar | 14,828,050,000 |
| 8 | EconomicCapitalRatio | 2.36 |
Edgar->Model Mapping
Feature Distribution
Change over Time
